Targeted Therapy and Immunotherapy in Melanoma

被引：46

作者：

Lazaroff, Jake ^{[1
]}

Bolotin, Diana ^{[1
]}

机构：

[1] Univ Chicago, Univ Chicago Med, Dept Med, Sect Dermatol, 5841 S Maryland Ave MC 5067, Chicago, IL 60637 USA

来源：

DERMATOLOGIC CLINICS | 2023年 / 41卷 / 01期

关键词：

Melanoma; Targeted; Therapy; Immunotherapy; DABRAFENIB PLUS TRAMETINIB; OPEN-LABEL; DOUBLE-BLIND; STAGE-III; METASTATIC MELANOMA; ADJUVANT DABRAFENIB; COMBINED NIVOLUMAB; IMPROVED SURVIVAL; MUTANT MELANOMA; SAFETY ANALYSIS;

D O I：

10.1016/j.det.2022.07.007

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：65 / 77

页数：13

共 83 条

[1] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma [J].

Amaria, Rodabe N. ;

Reddy, Sangeetha M. ;

Tawbi, Hussein A. ;

Davies, Michael A. ;

Ross, Merrick, I ;

Glitza, Isabella C. ;

Cormier, Janice N. ;

Lewis, Carol ;

Hwu, Wen-Jen ;

Hanna, Ehab ;

Diab, Adi ;

Wong, Michael K. ;

Royal, Richard ;

Gross, Neil ;

Weber, Randal ;

Lai, Stephen Y. ;

Ehlers, Richard ;

Blando, Jorge ;

Milton, Denai R. ;

Woodman, Scott ;

Kageyama, Robin ;

Wells, Daniel K. ;

Hwu, Patrick ;

Patel, Sapna P. ;

Lucci, Anthony ;

Hessel, Amy ;

Lee, Jeffrey E. ;

Gershenwald, Jeffrey ;

Simpson, Lauren ;

Burton, Elizabeth M. ;

Posada, Liberty ;

Haydu, Lauren ;

Wang, Linghua ;

Zhang, Shaojun ;

Lazar, Alexanderj ;

Hudgens, Courtney W. ;

Gopalakrishnan, Vancheswaran ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Spencer, Christine N. ;

Prieto, Victor ;

Sharma, Padmanee ;

Allison, James ;

Tetzlaff, Michael T. ;

Wargo, Jennifer A. .

NATURE MEDICINE, 2018, 24 (11) :1649-+

[2] Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial [J].

Amaria, Rodabe N. ;

Prieto, Peter A. ;

Tetzlaff, Michael T. ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Ross, Merrick J. ;

Glitza, Isabella C. ;

Cormier, Janice ;

Hwu, Wen-Jen ;

Tawbi, Hussein A. ;

Patel, Sapna P. ;

Lee, Jeffrey E. ;

Gersbenwaid, Jeffrey E. ;

Spencer, Christine N. ;

Gopalakrishnan, Vancheswaran ;

Bassett, Roland ;

Simpson, Lauren ;

Mouton, Rosalind ;

Hudgens, Courtney W. ;

Zhao, Li ;

Zhu, Haifeng ;

Cooper, Zachary A. ;

Wani, Khalida ;

Lazar, Alexander ;

Hwu, Patrick ;

Diab, Adi ;

Wong, Michael K. ;

McQuade, Jennifer L. ;

Royal, Richard ;

Lucci, Anthony ;

Burton, Elizabeth M. ;

Reddy, Sangeetha ;

Sharma, Padmanee ;

Allison, James ;

Futreal, Phillip A. ;

Woodman, Scott E. ;

Davies, Michael A. ;

Wargo, Jennifer A. .

LANCET ONCOLOGY, 2018, 19 (02) :181-193

[3] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].

Andtbacka, Robert H. I. ;

Kaufman, Howard L. ;

Collichio, Frances ;

Amatruda, Thomas ;

Senzer, Neil ;

Chesney, Jason ;

Delman, Keith A. ;

Spitler, Lynn E. ;

Puzanov, Igor ;

Agarwala, Sanjiv S. ;

Milhem, Mohammed ;

Cranmer, Lee ;

Curti, Brendan ;

Lewis, Karl ;

Ross, Merrick ;

Guthrie, Troy ;

Linette, Gerald P. ;

Daniels, Gregory A. ;

Harrington, Kevin ;

Middleton, Mark R. ;

Miller, Wilson H., Jr. ;

Zager, Jonathan S. ;

Ye, Yining ;

Yao, Bin ;

Li, Ai ;

Doleman, Susan ;

VanderWalde, Ari ;

Gansert, Jennifer ;

Coffin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98

[4] Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial [J].

Andtbacka, Robert H. I. ;

Ross, Merrick ;

Puzanov, Igor ;

Milhem, Mohammed ;

Collichio, Frances ;

Delman, Keith A. ;

Amatruda, Thomas ;

Zager, Jonathan S. ;

Cranmer, Lee ;

Hsueh, Eddy ;

Chen, Lisa ;

Shilkrut, Mark ;

Kaufman, Howard L. .

ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (13) :4169-4177

[5] Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy [J].

Anforth, Rachael ;

Menzies, Alexander ;

Byth, Karen ;

Carlos, Giuliana ;

Chou, Shaun ;

Sharma, Raghwa ;

Scolyer, Richard A. ;

Kefford, Richard ;

Long, Georgina V. ;

Fernandez-Penas, Pablo .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) :809-+

[6] Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial [J].

Ascierto, Paolo A. ;

McArthur, Grant A. ;

Dreno, Brigitte ;

Atkinson, Victoria ;

Liszkay, Gabrielle ;

Di Giacomo, Anna Maria ;

Mandala, Mario ;

Demidov, Lev ;

Stroyakovskiy, Daniil ;

Thomas, Luc ;

de la Cruz-Merino, Luis ;

Dutriaux, Caroline ;

Garbe, Claus ;

Yan, Yibing ;

Wongchenko, Matthew ;

Chang, Ilsung ;

Hsu, Jessie J. ;

Koralek, Daniel O. ;

Rooney, Isabelle ;

Ribas, Antoni ;

Larkin, James .

LANCET ONCOLOGY, 2016, 17 (09) :1248-1260

[7] Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma [J].

Ascierto, Paolo Antonio ;

Ferrucci, Pier Francesco ;

Fisher, Rosalie ;

Del Vecchio, Michele ;

Atkinson, Victoria ;

Schmidt, Henrik ;

Schachter, Jacob ;

Queirolo, Paola ;

Long, Georgina V. ;

Di Giacomo, Anna Maria ;

Svane, Inge Marie ;

Lotem, Michal ;

Bar-Sela, Gil ;

Couture, Felix ;

Mookerjee, Bijoyesh ;

Ghori, Razi ;

Ibrahim, Nageatte ;

Moreno, Blanca Homet ;

Ribas, Antoni .

NATURE MEDICINE, 2019, 25 (06) :941-+

[8] Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma [J].

Bajor, David L. ;

Mick, Rosemarie ;

Riese, Matthew J. ;

Richman, Lee P. ;

Xu, Xiaowei ;

Torigian, Drew A. ;

Stelekati, Erietta ;

Sweeney, Martha ;

Sullivan, Brendan ;

Schuchter, Lynn M. ;

Amaravadi, Ravi ;

Wherry, E. John ;

Vonderheide, Robert H. .

CANCER RESEARCH, 2015, 75

[9]

Byers B, 2013, CAN J PLAST SURG, V21, P142

[10]

Cancer Institute National, MELANOMA SKINCANCER

← 1 2 3 4 5 6 7 8 9 →